Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 50044799
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030792BDBM50030792(CHEMBL3342401)
Affinity DataIC50: 77nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030795BDBM50030795(CHEMBL3342398)
Affinity DataIC50: 120nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030794BDBM50030794(CHEMBL3342399)
Affinity DataIC50: 160nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030793BDBM50030793(CHEMBL3342400)
Affinity DataIC50: 190nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030798BDBM50030798(CHEMBL3342395)
Affinity DataIC50: 220nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030797BDBM50030797(CHEMBL3342396)
Affinity DataIC50: 750nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030813BDBM50030813(CHEMBL3355142)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030796BDBM50030796(CHEMBL3342397)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030800BDBM50030800(CHEMBL3342393)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030791BDBM50030791(CHEMBL3342402)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030801BDBM50030801(CHEMBL3342392)
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030799BDBM50030799(CHEMBL3342394)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030804BDBM50030804(CHEMBL3342389)
Affinity DataIC50: 5.50E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030805BDBM50030805(CHEMBL3342388)
Affinity DataIC50: 8.10E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030812BDBM50030812(CHEMBL3342381)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030807BDBM50030807(CHEMBL3342386)
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030806BDBM50030806(CHEMBL3342387)
Affinity DataIC50: 5.60E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030811BDBM50030811(CHEMBL3342382)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030809BDBM50030809(CHEMBL3342384)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030810BDBM50030810(CHEMBL3342383)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030808BDBM50030808(CHEMBL3342385)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030803BDBM50030803(CHEMBL3342390)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50030802BDBM50030802(CHEMBL3342391)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed